(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 0.53% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 0%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.64%.
Revvity's revenue in 2023 is $2,795,884,000.On average, 6 Wall Street analysts forecast RVTY's revenue for 2023 to be $335,981,524,686, with the lowest RVTY revenue forecast at $335,050,786,920, and the highest RVTY revenue forecast at $336,695,065,625. On average, 6 Wall Street analysts forecast RVTY's revenue for 2024 to be $341,488,328,099, with the lowest RVTY revenue forecast at $338,135,969,120, and the highest RVTY revenue forecast at $344,355,696,435.
In 2025, RVTY is forecast to generate $370,515,203,124 in revenue, with the lowest revenue forecast at $367,136,681,800 and the highest revenue forecast at $375,704,849,806.